Literature DB >> 20574691

Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention.

Kosmas I Paraskevas1, Ioannis Kotsikoris, Sotirios A Koupidis, Alexandros A Tzovaras, Dimitri P Mikhailidis.   

Abstract

Cardiovascular disease is the leading cause of death in both chronic kidney disease and peritoneal dialysis/hemodialysis patients. Vascular disease prevention in these patients is therefore important to reduce the incidence of cardiovascular events and the high morbidity and mortality. This Editorial discusses the traditional, (1) smoking, (2) dyslipidemia, (3) body mass index, (4) glycemic control and (5) blood pressure, and non-traditional, (1) anemia, (2) vitamin D/hyperparathyroidism, (3) calcium/phosphorus metabolism and (4) magnesium, risk factors in renal patients. Current evidence does not support routine statin use and antiplatelet medication to dialysis patients. Patient compliance and adherence to proposed measures could be essential to reduce cardiovascular events and mortality rates in this high-risk population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20574691     DOI: 10.1007/s11255-010-9795-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  73 in total

Review 1.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

2.  Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

Review 3.  Predictors of cardiovascular death in ESRD.

Authors:  Carmine Zoccali; Giovanni Tripepi; Francesca Mallamaci
Journal:  Semin Nephrol       Date:  2005-11       Impact factor: 5.299

Review 4.  Rosuvastatin: efficacy, safety and clinical effectiveness.

Authors:  Handrean Soran; Paul Durrington
Journal:  Expert Opin Pharmacother       Date:  2008-08       Impact factor: 3.889

Review 5.  Promoting functioning and well-being in older CKD patients: review of recent evidence.

Authors:  Nancy G Kutner
Journal:  Int Urol Nephrol       Date:  2008-09-12       Impact factor: 2.370

6.  Critical limb ischaemia as a main cause of death in patients with end-stage renal disease: a single-centre study.

Authors:  Michael Koch; Rudolf Trapp; Wolfgang Kulas; Bernd Grabensee
Journal:  Nephrol Dial Transplant       Date:  2004-07-20       Impact factor: 5.992

Review 7.  Dyslipidemia as a risk factor for ischemic stroke.

Authors:  Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

8.  Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.

Authors:  Mitsuteru Matsuoka; Kunitoshi Iseki; Masahiro Tamashiro; Naoko Fujimoto; Nobuyoshi Higa; Takashi Touma; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2004-03       Impact factor: 2.801

9.  Chronic kidney disease stages 3-5 and cardiovascular disease in the veterans affairs population.

Authors:  Debasish Banerjee; Gabriel Contreras; Isabel Jaraba; Decio Carvalho; Luis Ortega; Cristiane Carvalho; Candido Pezon; Stephen P Rosenthal; Norman De La Rosa; Nuripama Vemuri; Gautam Cherla; Nilay Nahar
Journal:  Int Urol Nephrol       Date:  2009-01-01       Impact factor: 2.370

10.  Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Brian D Bradbury; Rachel B Fissell; Justin M Albert; Mary S Anthony; Cathy W Critchlow; Ronald L Pisoni; Friedrich K Port; Brenda W Gillespie
Journal:  Clin J Am Soc Nephrol       Date:  2006-11-29       Impact factor: 8.237

View more
  10 in total

1.  Screening for peripheral artery disease in dialysis patients: an opportunity for early disease detection and timely initiation of appropriate therapeutic measures.

Authors:  Kosmas I Paraskevas; Sotirios A Koupidis; Alexandros A Tzovaras; Achilleas Nikolaou; Dimitri P Mikhailidis
Journal:  Int Urol Nephrol       Date:  2011-01-06       Impact factor: 2.370

2.  Presence of glucose in dialyzing fluid and synthesis of selected lipoxygenase-derived eicosanoids during hemodialysis.

Authors:  Barbara Dołęgowska; Wojciech Błogowski; Joanna Stępniewska; Krzysztof Safranow; Katarzyna Jakubowska; Maria Olszewska
Journal:  Int Urol Nephrol       Date:  2011-11-30       Impact factor: 2.370

3.  Arginase type I as a marker of coronary heart disease in hemodialysis patients.

Authors:  Theodoros Eleftheriadis; Vassilios Liakopoulos; Georgia Antoniadi; Ioannis Stefanidis; Grammati Galaktidou
Journal:  Int Urol Nephrol       Date:  2010-09-15       Impact factor: 2.370

4.  Association of peripheral artery disease and long-term mortality in hemodialysis patients.

Authors:  Shigeru Otsubo; Mariko Kitamura; Takako Wakaume; Aiji Yajima; Miwa Ishihara; Masayo Takasaki; Syuitsu Ueda; Hisayuki Sugimoto; Kimiko Otsubo; Naoki Kimata; Takashi Akiba; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2010-12-14       Impact factor: 2.370

5.  Oxidative stress accelerates the carotid atherosclerosis process in patients with chronic kidney disease.

Authors:  Leila Azouaou Toualbi; Mounir Adnane; Khelfi Abderrezak; Wafa Ballouti; Medina Arab; Chahine Toualbi; Henni Chader; Ryne Tahae; Atmane Seba
Journal:  Arch Med Sci Atheroscler Dis       Date:  2020-09-14

6.  Improvement and influencing factors of blood pressure control by nephrologist referral in chronic kidney disease patients in China: a cohort study.

Authors:  Li-Yan Wang; Dao-Xin Yin; Dong-Liang Zhang; Rui Xu; Wen-Ying Cui; Wen-Hu Liu
Journal:  Int Urol Nephrol       Date:  2012-12-07       Impact factor: 2.370

7.  Twenty four-hour ambulatory blood pressure monitoring and lipid levels before, 3, 6 and 12 months after the onset of hemodialysis in chronic kidney disease patients: a pilot study.

Authors:  Ag Vagiona; Sa Koupidis; P Passadakis; El Thodis; V Vargemezis
Journal:  Hippokratia       Date:  2012-04       Impact factor: 0.471

8.  Association of adiponectin with peripheral arterial disease and mortality in nondiabetic hemodialysis patients: Long-term follow-up data of 7 years.

Authors:  Yijun Zhou; Jiwei Zhang; Weiming Zhang; Zhaohui Ni
Journal:  J Res Med Sci       Date:  2016-06-14       Impact factor: 1.852

9.  Prognostic performance of combined use of high-sensitivity troponin T and creatine kinase MB isoenzyme in high cardiovascular risk patients with end-stage renal disease.

Authors:  Khaled Abdul-Aziz Ahmed; Wahda Mohammed Al-Attab
Journal:  Kidney Res Clin Pract       Date:  2017-12-31

10.  Implications of advanced oxidation protein products and vitamin E in atherosclerosis progression.

Authors:  Leila Azouaou Toualbi; Adnane Mounir; Ballouti Wafa; Arab Medina; Khelfi Abderrezak; Toualbi Chahine; Chader Henni; Bennoui Abdelghani; Seba Atmane
Journal:  Arch Med Sci Atheroscler Dis       Date:  2021-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.